274 related articles for article (PubMed ID: 28498717)
21. Toxicity induced by chemical warfare agents: insights on the protective role of melatonin.
Pita R; Marco-Contelles J; Ramos E; Del Pino J; Romero A
Chem Biol Interact; 2013 Nov; 206(2):134-42. PubMed ID: 24035908
[TBL] [Abstract][Full Text] [Related]
22. [Melatonin as a drug: present status and perspectives].
Arushanian ÉB
Eksp Klin Farmakol; 2014; 77(6):39-44. PubMed ID: 25102735
[TBL] [Abstract][Full Text] [Related]
23. Molecular Hybridization as a Tool in the Design of Multi-target Directed Drug Candidates for Neurodegenerative Diseases.
Gontijo VS; Viegas FPD; Ortiz CJC; de Freitas Silva M; Damasio CM; Rosa MC; Campos TG; Couto DS; Tranches Dias KS; Viegas C
Curr Neuropharmacol; 2020; 18(5):348-407. PubMed ID: 31631821
[TBL] [Abstract][Full Text] [Related]
24. The chemistry toolbox of multitarget-directed ligands for Alzheimer's disease.
Mesiti F; Chavarria D; Gaspar A; Alcaro S; Borges F
Eur J Med Chem; 2019 Nov; 181():111572. PubMed ID: 31404859
[TBL] [Abstract][Full Text] [Related]
25. Cystamine-tacrine dimer: a new multi-target-directed ligand as potential therapeutic agent for Alzheimer's disease treatment.
Minarini A; Milelli A; Tumiatti V; Rosini M; Simoni E; Bolognesi ML; Andrisano V; Bartolini M; Motori E; Angeloni C; Hrelia S
Neuropharmacology; 2012 Feb; 62(2):997-1003. PubMed ID: 22032870
[TBL] [Abstract][Full Text] [Related]
26. Modulation of serine/threonine phosphatases by melatonin: therapeutic approaches in neurodegenerative diseases.
Arribas RL; Romero A; Egea J; de Los Ríos C
Br J Pharmacol; 2018 Aug; 175(16):3220-3229. PubMed ID: 29781146
[TBL] [Abstract][Full Text] [Related]
27. [Novel agonists of melatonin receptors as promising hypotensive and neuroprotective agents for therapy of glaucoma].
Chesnokova NB; Beznos OV; Lozinskaya NA; Volkova MS; Zaryanova EV; Zefirov NA; Grigoryev AV
Biomed Khim; 2017 Jan; 63(1):75-80. PubMed ID: 28251954
[TBL] [Abstract][Full Text] [Related]
28. New multifunctional melatonin-derived benzylpyridinium bromides with potent cholinergic, antioxidant, and neuroprotective properties as innovative drugs for Alzheimer's disease.
Luo XT; Wang CM; Liu Y; Huang ZG
Eur J Med Chem; 2015 Oct; 103():302-11. PubMed ID: 26363866
[TBL] [Abstract][Full Text] [Related]
29. Melatonin prevents glutamate-induced oxytosis in the HT22 mouse hippocampal cell line through an antioxidant effect specifically targeting mitochondria.
Herrera F; Martin V; García-Santos G; Rodriguez-Blanco J; Antolín I; Rodriguez C
J Neurochem; 2007 Feb; 100(3):736-46. PubMed ID: 17263795
[TBL] [Abstract][Full Text] [Related]
30. Melatonin hormone as a therapeutic weapon against neurodegenerative diseases.
Asefy Z; Khusro A; Mammadova S; Hoseinnejhad S; Eftekhari A; Alghamdi S; Dablool AS; Almehmadi M; Kazemi E; Sahibzada MUK
Cell Mol Biol (Noisy-le-grand); 2021 Nov; 67(3):99-106. PubMed ID: 34933727
[TBL] [Abstract][Full Text] [Related]
31. Promising Role of Melatonin as Neuroprotectant in Neurodegenerative Pathology.
Joshi N; Biswas J; Nath C; Singh S
Mol Neurobiol; 2015 Aug; 52(1):330-40. PubMed ID: 25159482
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis and biological evaluation of multifunctional tacrine-curcumin hybrids as new cholinesterase inhibitors with metal ions-chelating and neuroprotective property.
Liu Z; Fang L; Zhang H; Gou S; Chen L
Bioorg Med Chem; 2017 Apr; 25(8):2387-2398. PubMed ID: 28302511
[TBL] [Abstract][Full Text] [Related]
33. Melatonin ameliorates amyloid beta-induced memory deficits, tau hyperphosphorylation and neurodegeneration via PI3/Akt/GSk3β pathway in the mouse hippocampus.
Ali T; Kim MO
J Pineal Res; 2015 Aug; 59(1):47-59. PubMed ID: 25858697
[TBL] [Abstract][Full Text] [Related]
34. Melatonin Attenuates Memory Impairment, Amyloid-β Accumulation, and Neurodegeneration in a Rat Model of Sporadic Alzheimer's Disease.
Rudnitskaya EA; Muraleva NA; Maksimova KY; Kiseleva E; Kolosova NG; Stefanova NA
J Alzheimers Dis; 2015; 47(1):103-16. PubMed ID: 26402759
[TBL] [Abstract][Full Text] [Related]
35. Role of Melatonin in the Inflammatory Process and its Therapeutic Potential.
Carrascal L; Nunez-Abades P; Ayala A; Cano M
Curr Pharm Des; 2018; 24(14):1563-1588. PubMed ID: 29701146
[TBL] [Abstract][Full Text] [Related]
36. Neuroprotective Role of Natural Polyphenols.
Spagnuolo C; Napolitano M; Tedesco I; Moccia S; Milito A; Russo GL
Curr Top Med Chem; 2016; 16(17):1943-50. PubMed ID: 26845551
[TBL] [Abstract][Full Text] [Related]
37. The emergence of designed multiple ligands for neurodegenerative disorders.
Geldenhuys WJ; Youdim MB; Carroll RT; Van der Schyf CJ
Prog Neurobiol; 2011 Sep; 94(4):347-59. PubMed ID: 21536094
[TBL] [Abstract][Full Text] [Related]
38. Role of melatonin in traumatic brain injury and spinal cord injury.
Naseem M; Parvez S
ScientificWorldJournal; 2014; 2014():586270. PubMed ID: 25587567
[TBL] [Abstract][Full Text] [Related]
39. Relevance of the chronobiological and non-chronobiological actions of melatonin for enhancing therapeutic efficacy in neurodegenerative disorders.
Cecon E; Markus RP
Recent Pat Endocr Metab Immune Drug Discov; 2011 May; 5(2):91-9. PubMed ID: 22074584
[TBL] [Abstract][Full Text] [Related]
40. Melatonin Can Modulate Neurodegenerative Diseases by Regulating Endoplasmic Reticulum Stress.
Yoo YM; Joo SS
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
